Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Hematology Drugs Market Global Briefing 2017

Hematology Drugs Market Global Briefing 2017

From $1,000.00

Including: Blood Products, Anemia And Other Blood Disorder Drugs.
Covering: Novo Nordisk A/S, Shire Plc., Bayer AG, Daiichi Sankyo Company, Limited, Biogen Inc., Pfizer Inc.


Clear selection
SKU: 2275. Categories: , .
Description

The market segments in the hematology drugs market include blood products accounting for over 72% share of the market and anemia and other blood disorder drugs accounting for around 25% share of the market.

Hematology Drugs Market Global Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the hematology drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the hematology drugs market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the hematology drugs market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.

 

Scope

Markets Covered: Blood Products, Anemia And Other Blood Disorder Drugs.
Companies Mentioned: Novo Nordisk A/S, Shire Plc., Bayer AG, Daiichi Sankyo Company Limited, Biogen Inc., Pfizer Inc.
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

 

Executive Summary
Hematology drugs market offers drugs, blood and blood products that are used for the treatment of diseases such as rare genetic disorders, anemia, and conditions related to sickle cell disease and other related diseases. Some of the major hematology drugs include Albumin, Epoetin, Zoladex, and Hyskon.

The global hematology drugs market is expected to reach around $45 billion in 2020. Going forward, unhealthy lifestyle leading to anemia and coagulation disorders, along with increased longevity and the launch of pipeline drugs is set to drive the market for hematology drugs.

Tranexamic Acid To Prevent Postpartum Hemorrhage - Tranexamic acid is increasingly being used to prevent postpartum hemorrhage (blood loss of over 500 ml or 1,000 ml within 24 hours of childbirth) due to its cheap price and wide availability. Tranexamic acid is an antifibrinolytic drug that helps in reducing bleeding in surgical and trauma patients, including women with postpartum hemorrhage. In April 2017, WOMAN (World Maternal Antifibrinolytic), an international, randomized, double-blind, placebo-controlled trial including over 20,000 women from 193 hospitals in 21 countries, found that using tranexamic acid within three hours of childbirth lowered death from bleeding by 31% and reduced the need for laparotomy (emergency bleeding control surgery) by 36%, as compared to placebo.
Table of Contents
Hematology Drugs Market Characteristics 4
Hematology Drugs Market Historic Growth 5
Hematology Drugs Market Forecast Growth 6
Hematology Drugs Market Segmentation 7
Global Hematology Drugs Market, Split By Segments, 2016, $ Billion 7
Blood Products 7
Anemia And Other Blood Disorder Drugs 8
Global Hematology Drugs Market, Historic and Forecast, Split By Segments, 2012-2020 9
Hematology Drugs Market Geography Regional and Country Comparison 10
Global Hematology Drugs Market, Split By Regions, 2016 10
Global Hematology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 12
Global Hematology Drugs Market, Split By Country, 2016 14
Global Hematology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 15
Hematology Drugs Market Competitive Landscape 17
Novo Nordisk A/S 18
Daiichi Sankyo Company, Limited 18
Bayer AG 18
Biogen Inc. 18
Pfizer Inc. 18
Shire Plc. 18
Novo Nordisk 19
Shire Plc. 19
Bayer AG 20
Hematology Drugs Market Key Mergers And Acquisitions 21
Sumitomo Dainippon Pharma Co. Ltd. Acquired Tolero Pharmaceuticals 21
Novartis Acquired Selexys Pharmaceuticals Corporation And SelG1 Antibody 21
Miragen Therapeutics, Inc. Merged With Signal Genetics, Inc. 21
RXi Pharmaceuticals Acquired MirImmune Inc. 21
Sorrento Therapeutics, Inc., Merged With Yuhan Corporation 21
Hematology Drugs Market Trends And Strategies 22
Tranexamic Acid To Prevent Postpartum Hemorrhage 22
Increase In Product Approvals for Hemophilia 22
Gene Therapy For Treatment Of Sickle-Cell Disease 22
Genetically Engineered Drug For Von Willebrand Disease (VWD) 23
Appendix 24
NAICS Definitions Of Industry Covered In This Report 24
Definition Of Market Covered In This Report 24
Abbreviations 24
Currencies 24
Research Methodology 25
Research Inquiries 26
The Business Research Company 26

List of Figures
Figure 1: Global Hematology Drugs Market, Historic Market Size, 2012-2016, $ Billion 5
Figure 2: Global Hematology Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion 6
Figure 3: Global Hematology Drugs Market, Split By Segments, 2016, $ Billion 7
Figure 4: Global Hematology Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020 9
Figure 5: Global Hematology Drugs Market, Split By Region, 2016, $ Billion 10
Figure 6: Global Hematology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 12
Figure 7: Global Hematology Drugs Market, Split By Country, 2016, $ Billion 14
Figure 8: Global Hematology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 15
Figure 9: Global Hematology Drugs Market, Key Competitor Market Shares, 2016, Percentage (%) 17

List of Tables
Table 1: Global Hematology Drugs Market, Historic Market Size, 2012-2016, $ Billion 5
Table 2: Global Hematology Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion 6
Table 3: Global Hematology Drugs Market, Split By Segments, 2016, $ Billion 7
Table 4: Global Hematology Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020 9
Table 5: Global Hematology Drugs Market, Split By Region, 2016, $ Billion 11
Table 6: Global Hematology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 12
Table 7: Global Hematology Drugs Market, Split By Country, 2016, $ Billion 14
Table 8: Global Hematology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 16
Table 9: Global Hematology Drugs Market, Key Competitor Market Shares, 2016, Percentage (%) 18
Get Customized Report
Please fill in your details. Our team will get back to you